Novothyrox Articles
Harmful drug-drug interactions for thyroid medicines identified
15 September 2008
Revised monograph for levothyroxine to be issued in USA
4 August 2008
FDA rates Lannett's levothyroxine AB
20 December 2004
KV resolves a handful of legal matters
20 September 2004
King's 2nd-qtr net loss rockets 81%
16 August 2004
King Pharma posts 36% leap in earnings
5 August 2002
Showing 1-7 of 7 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
